Julio Rosenstock<br />Oct 1, 2020; 43:2509-2518<br />Emerging Therapies: Drugs and Regimens
…. more: Diabetes Journals (ADA) (Quelle/Source)
Aktuelle Seite: Startseite / Diabetes / Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
